All Stories

  1. Transcriptomic profiling of HHLA2 (B7-H7)-driven suppression in natural killer cells

    Article • Cancer Research, April 2025, American Association for Cancer Research (AACR)

    Deepthi Chowbene

  2. Targeting HHLA2 (B7-H7) reveals subset-specific transcriptional changes in NK cells

    Article • Cancer Research, March 2025, American Association for Cancer Research (AACR)

    Deepthi Chowbene

  3. Post-hoc Analysis of KIM-1 as a Biomarker in Advanced RCC (CheckMate 214)

    Article • Journal of Clinical Oncology, February 2025, American Society of Clinical Oncology (ASCO)

    Deepthi Chowbene

  4. Integrative biomarkers from CheckMate 914 trial: Nivolumab ± Ipilimumab in ccRCC

    Article • November 2024, BMJ

    Deepthi Chowbene